REGN Sentiment Analysis
We collect and analyze sentiment surrounding REGN stock to help you make informed investment decisions.
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.37% Profit: QuantWave Analysis
Published on August 15, 2024
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Achieves Price Target Forecast with 18.25% Profit
Published on August 15, 2024
REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, with a profit of 18.25%....
Successfully Achieved Price Target Forecast for Regeneron Pharmaceuticals, Inc. with 19.42% Profit
Published on August 13, 2024
QuantWave, the automated forecasting platform, recently celebrated the successful achievement of its price target forecast for Regeneron Pharmaceuticals, Inc. On May 7, 2024, the forecast signal indicated a long position for the stock, which was trad...
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.03% Profit – QuantWave Success Story
Published on August 13, 2024
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 14.62%
Published on August 13, 2024
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 14.62% Profit
Published on August 13, 2024
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave's Price Target Forecast with 19.42% Profit
Published on August 13, 2024
Amidst the ever-evolving landscape of the stock market, QuantWave's automated forecasting platform recently achieved a significant milestone with its accurate prediction for REGENERON PHARMACEUTICALS, INC. On May 7, 2024, the platform issued a long s...
REGENERON PHARMACEUTICALS, INC. Hits 19.03% Profit Target as Forecasted by QuantWave
Published on August 13, 2024
On May 28, 2024, QuantWave's automated forecasting platform issued a long signal for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Price Target with 15.92% Profit
Published on June 14, 2024
REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Achieves Price Target Forecast Success with 15.92% Profit
Published on June 14, 2024
On April 16, 2024, QuantWave's forecast signal indicated a long position for REGENERON PHARMACEUTICALS, INC. at a price of $890....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 22.38% Profit: A Success Story for QuantWave
Published on October 13, 2022
On August 4, 2022, QuantWave, the automated forecasting platform, issued a long signal for REGENERON PHARMACEUTICALS, INC....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 22.38% Profit: QuantWave's Success
Published on October 13, 2022
On August 4, 2022, QuantWave issued a long signal for REGENERON PHARMACEUTICALS, INC. with a price target of $749.35....
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 22.38% Profit
Published on October 13, 2022
On August 4th, 2022, QuantWave's forecasting platform identified REGENERON PHARMACEUTICALS, INC....